Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-06

FDA Approved: CETRORELIX — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for cetrorelix acetate by Teva Pharmaceuticals, updating the drug's approval status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetrorelix (Cetrorelix acetate)

Snippet

SUPPL AP for CETRORELIX (CETRORELIX ACETATE)